Skip to content

A Study on the Application of Baduanjin Based on Digital Therapy in Patients with Dyslipidemia

A Study on the Application of Baduanjin Based on Digital Therapy in Patients with Dyslipidemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000552
Enrollment
Unknown
Registered
2024-10-14
Start date
2024-10-20
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

Experimental group:Baduanjin treatment based on digital therapy
Control group:Health Management

Sponsors

Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Age between 15 and 75 years old; 2. Patients diagnosed with dyslipidemia: Under normal dietary conditions blood lipid levels are measured after a 12-14 hour fasting period. Serum total cholesterol (TC) = 5.20 mmol/L; Serum triglycerides (TG) = 1.70 mmol/L; Low-density lipoprotein cholesterol (LDL-C) = 3.40 mmol/L; High-density lipoprotein cholesterol (HDL-C) = 1.0 mmol/L. Meeting any one of the above conditions is sufficient. 3. Patients with clear consciousness normal cognitive function and stable condition; 4. Patients or long-term caregivers who have and know how to use a smartphone; 5. Informed consent and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Patients with severe cardiovascular hematological neurological respiratory system diseases or malignant tumors; 2. Patients who have received lipid-lowering treatment in the past 3 months or are currently taking medications that may affect lipid metabolism (such as heparin thyroxine etc.); 3. Patients who are unable to take care of themselves and cannot cooperate with the Baduanjin rehabilitation exercise; 4. Pregnant or lactating women; 5. Patients with excessively high blood lipids or high risk of ASCVD: TG > 5.6 mmol/L or TC > 7.20 mmol/L or LDL-C > 4.90 mmol/L.

Design outcomes

Primary

MeasureTime frame
High density lipoprotein cholesterol;triglyceride;total cholesterol;Low density lipoprotein cholesterol;

Secondary

MeasureTime frame
ApoB;Body Mass Index;Waist circumference;Lp(a);ApoA;

Countries

China

Contacts

Public ContactWang Yi

Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine)

17826879228@163.com18958070200

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026